Wednesday, July 8, 2026

Patent intelligence · US

US 12295394

Water-soluble additive composition

granted A61KA61K2800/10A61K8/365A61K8/368
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 19
Applicant portfolio 26
Patent details — US 12295394
Jurisdiction
US
Status
granted
Grant date
May 13, 2025
Expiration
May 8, 2045
Claims
8
CPC classes
A61K, A61K2800/10, A61K8/365, A61K8/368
View on Google Patents ↗

Quick answer

US 12295394 (Water-soluble additive composition) is held by SUMITOMO BAKELITE CO., LTD.. Status: granted. Granted May 13, 2025. Expires May 8, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
8
CPC classes
A61K, A61K2800/10, A61K8/365, A61K8/368, A61K8/44, A61K8/445

More from SUMITOMO BAKELITE CO., LTD.

Related pharmaceutical patents in our USPTO index.

  1. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Belite Bio, Inc · Expires Jul 17, 2045

    granted
  2. US 12116596

    Method and apparatus for improved mesenchymal stem cell harvesting

    Elite IP, LLC · Expires Oct 10, 2044

    granted
  3. US 12016853

    Methods of treating RBP4 related diseases with triazolopyridines

    Belite Bio, Inc · Expires Jun 20, 2044

    granted
  4. US 11951100

    Formulations of RBP4 inhibitors and methods of use

    Belite Bio, Inc · Expires Apr 4, 2044

    granted
  5. US 11723873

    Oral dosage form of ticagrelor and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Expires Aug 10, 2043

    granted
  6. US 11684596

    Antidiabetic pharmaceutical compositions and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Expires Jun 22, 2043

    granted
  7. US 11655454

    Method and apparatus for improved mesenchymal stem cell harvesting

    Elite IP, LLC · Expires May 18, 2043

    granted

Frequently asked questions

What is US patent 12295394?

US 12295394 (Water-soluble additive composition) is held by SUMITOMO BAKELITE CO., LTD.. Status: granted. Granted May 13, 2025. Expires May 8, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 12295394?

SUMITOMO BAKELITE CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 26 pharmaceutical patents for this assignee.

When does US 12295394 expire?

Our index shows an expiration date of May 8, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.